SE9101509D0 - Receptor ligands - Google Patents

Receptor ligands

Info

Publication number
SE9101509D0
SE9101509D0 SE9101509A SE9101509A SE9101509D0 SE 9101509 D0 SE9101509 D0 SE 9101509D0 SE 9101509 A SE9101509 A SE 9101509A SE 9101509 A SE9101509 A SE 9101509A SE 9101509 D0 SE9101509 D0 SE 9101509D0
Authority
SE
Sweden
Prior art keywords
diiodo
benzofuran
pct
diethylaminoethoxy
benzoyl
Prior art date
Application number
SE9101509A
Other languages
English (en)
Inventor
J F Stearn
Original Assignee
Karobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9101509(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Karobio Ab filed Critical Karobio Ab
Priority to SE9101509A priority Critical patent/SE9101509D0/sv
Publication of SE9101509D0 publication Critical patent/SE9101509D0/sv
Priority to KR1019930703488A priority patent/KR100235778B1/ko
Priority to AU17743/92A priority patent/AU660681B2/en
Priority to AT92910804T priority patent/ATE141504T1/de
Priority to EP92910804A priority patent/EP0584186B1/en
Priority to ES92910804T priority patent/ES2090642T3/es
Priority to CA002109625A priority patent/CA2109625C/en
Priority to DK92910804.1T priority patent/DK0584186T3/da
Priority to PCT/SE1992/000307 priority patent/WO1992020331A1/en
Priority to DE69213003T priority patent/DE69213003T2/de
Priority to US08/142,350 priority patent/US5567728A/en
Priority to JP4509908A priority patent/JPH06507619A/ja
Priority to US08/480,643 priority patent/US5585404A/en
Priority to GR960403147T priority patent/GR3021744T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9101509A 1991-05-17 1991-05-17 Receptor ligands SE9101509D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9101509A SE9101509D0 (sv) 1991-05-17 1991-05-17 Receptor ligands
JP4509908A JPH06507619A (ja) 1991-05-17 1992-05-12 レセプターリガンド
US08/142,350 US5567728A (en) 1991-05-17 1992-05-12 Receptor ligands
ES92910804T ES2090642T3 (es) 1991-05-17 1992-05-12 Ligandos de receptores.
AU17743/92A AU660681B2 (en) 1991-05-17 1992-05-12 Receptor ligands
AT92910804T ATE141504T1 (de) 1991-05-17 1992-05-12 Rezeptorliganden
EP92910804A EP0584186B1 (en) 1991-05-17 1992-05-12 Receptor ligands
KR1019930703488A KR100235778B1 (ko) 1991-05-17 1992-05-12 T-3 조절 유전자 발현의존 질환의 치료 또는 예방약제와 약학적 조성물 및 화합물
CA002109625A CA2109625C (en) 1991-05-17 1992-05-12 3,5,3'-triiodothyronine receptor ligands
DK92910804.1T DK0584186T3 (da) 1991-05-17 1992-05-12 Receptorligander
PCT/SE1992/000307 WO1992020331A1 (en) 1991-05-17 1992-05-12 Receptor ligands
DE69213003T DE69213003T2 (de) 1991-05-17 1992-05-12 Rezeptorliganden
US08/480,643 US5585404A (en) 1991-05-17 1995-06-07 3,5,3'-triiodothyronine receptor ligands
GR960403147T GR3021744T3 (en) 1991-05-17 1996-11-20 Receptor ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101509A SE9101509D0 (sv) 1991-05-17 1991-05-17 Receptor ligands

Publications (1)

Publication Number Publication Date
SE9101509D0 true SE9101509D0 (sv) 1991-05-17

Family

ID=20382770

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101509A SE9101509D0 (sv) 1991-05-17 1991-05-17 Receptor ligands

Country Status (13)

Country Link
US (2) US5567728A (sv)
EP (1) EP0584186B1 (sv)
JP (1) JPH06507619A (sv)
KR (1) KR100235778B1 (sv)
AT (1) ATE141504T1 (sv)
AU (1) AU660681B2 (sv)
CA (1) CA2109625C (sv)
DE (1) DE69213003T2 (sv)
DK (1) DK0584186T3 (sv)
ES (1) ES2090642T3 (sv)
GR (1) GR3021744T3 (sv)
SE (1) SE9101509D0 (sv)
WO (1) WO1992020331A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316487B1 (en) 1993-06-16 2001-11-13 Aryx Therapeutics Compounds for treatment of cardiac arrhythmia synthesis, and methods of use
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
GB9416219D0 (en) * 1994-08-11 1994-10-05 Karobio Ab Receptor ligands
AU3791799A (en) * 1998-05-12 1999-11-29 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6166069A (en) 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
WO2001036351A2 (en) * 1999-11-19 2001-05-25 Corvas International, Inc. Plasminogen activator inhibitor antagonists related applications
US6638977B1 (en) 1999-11-19 2003-10-28 Corvas International, Inc. Plasminogen activator inhibitor antagonists
KR20040030818A (ko) * 2001-07-20 2004-04-09 카로 바이오 아베 심방 세동의 치료에 있어서의 벤조 퓨란 및 이들의 용도
ATE446300T1 (de) 2005-07-15 2009-11-15 Aryx Therapeutics Inc Antiarrhythmische vorläuferverbindungen, syntheseverfahren und verwendungsverfahren
US8454682B2 (en) 2010-04-13 2013-06-04 Medtronic Vascular, Inc. Anchor pin stent-graft delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) * 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
FR1224490A (fr) * 1959-05-14 1960-06-24 Du Pont Nouvelles matières thermoplastiques et leur procédé de fabrication
US3880891A (en) * 1973-09-21 1975-04-29 Smithkline Corp Substituted benzofurans
GB1495680A (en) * 1975-06-20 1977-12-21 May & Baker Ltd 1-(2-benzoylphenoxy)-2-hydroxy-3-aminopropanes
JPH02304022A (ja) * 1989-05-18 1990-12-17 Mitsubishi Kasei Corp セロトニン拮抗剤

Also Published As

Publication number Publication date
ATE141504T1 (de) 1996-09-15
DE69213003D1 (de) 1996-09-26
DK0584186T3 (da) 1996-09-09
GR3021744T3 (en) 1997-02-28
KR100235778B1 (ko) 1999-12-15
JPH06507619A (ja) 1994-09-01
WO1992020331A1 (en) 1992-11-26
AU1774392A (en) 1992-12-30
EP0584186B1 (en) 1996-08-21
US5567728A (en) 1996-10-22
EP0584186A1 (en) 1994-03-02
DE69213003T2 (de) 1997-02-06
CA2109625C (en) 2000-03-28
AU660681B2 (en) 1995-07-06
ES2090642T3 (es) 1996-10-16
US5585404A (en) 1996-12-17

Similar Documents

Publication Publication Date Title
ATE141504T1 (de) Rezeptorliganden
TW200607511A (en) Use of optically pure (S,S)-reboxetine in the manufacture of a medicament for the treatment or prevention of peripheral neuropathy
LU92154I2 (fr) Axitinib, éventuellement sous la forme d'un sel pharmaceutiquement acceptable
AP1398A (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives.
NO952890L (no) Kombinasjonsbehandling for inhibisjon av bentap
RU94045155A (ru) Способы ингибирования болезни альцгеймера
MY102565A (en) Novel derivatives of guanine
CA2252515A1 (en) Pharmaceutical compositions for prevention and treatment of central nervous system disorders
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
RU94044454A (ru) Ингибитор аутоимунных заболеваний
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
HUP9900905A2 (hu) D4-Vitamin származékok alkalmazása rák kezelésére szolgáló gyógyászati készítmények előállítására
RU94045277A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования расстройств цнс у женщин в постменопаузе
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
RU94045280A (ru) Средство для ингибирования патологических состояний молочных желез
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
Burdick et al. Chronic pancreatitis: selection of patients for endoscopic therapy
DK0738147T3 (da) Anvendelse af riluzol ved behandling af mitochondriesygdomme
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
ES2134361T3 (es) Compuestos de cromano neuroprotectores.
TW427978B (en) Tetrahydroisoquinoline derivatives
CA2543986A1 (en) Norepinephrine reuptake inhibitors and methods of using the same
MX9700775A (es) Derivados de tetrahidroisoquinolina.
KR980700074A (ko) 트리아릴-에틸렌 유도체를 사용하여 골다공증을 치료하거나 예방하는 방법(Method of Using Triaryl-Ethylene Derivatives in the Treament and Prevention of Osteoporosis)
MX9703611A (es) Uso de bis-arilfuranos en la preparacion de composiciones para la inhibicion de neumonia por pneumocystis carinii, giardia lamblia y criptosporidium parvum.